If oral Moxifloxacin cannot be administered for a penetrating eye injury, what alternative should be given?

When oral Moxifloxacin is not an option for a patient with a penetrating eye injury, the appropriate alternative is to administer antibiotics via intravenous (IV), intraosseous (IO), or intramuscular (IM) routes. This is essential due to the nature of penetrating eye injuries, which can lead to serious infections if not treated promptly and effectively.

Using IV, IO, or IM antibiotics ensures that the medication reaches the systemic circulation rapidly, providing a more immediate and potent response compared to oral administration, especially when dealing with potential threats of endophthalmitis or other serious infectious complications associated with such injuries. These routes allow for higher bioavailability and can be crucial in managing infections that can arise in these critical situations.

While other options may provide supportive care or localized treatment, only systemic antibiotics delivered through IV, IO, or IM can address the urgent need for effective infection control in the context of a penetrating eye injury.